References
- Kenny AJ, Booth AG, George SG, Ingram J, Kershaw D, Wood EJ, et al. Dipeptidyl peptidase IV, a kidney brush border serine peptidase. Biochem J 1976;157:169–82.
- Hegen M, Nedbitek G, Eberhart Klein C, Stein H, Fleischer B. The T cell triggering molecule Tp 103 is associated with dipeptidyl peptidase IV activity. J Immunol 1990;144: 2908–14.
- Mentzel S, Dijkman HBPM, Van Son JPHF, Koene RAP, Assmann KJM. Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice. J Hystochem Cytochem 1996;44:445–61.
- Scalan MJ, Mohan Raj BK, Calvo B, Garin-Chese P, Sanz-Moncasi MP, Healey JH, et al. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelian cancers. Proc Natl Acad Sci USA 1994;91:5657–61.
- Fleischer B. CD26: a surface protease involved in T-cell activation. Immunology Today 1994;15:180–4.
- Lakatos PL, Firneisz G, Rakoczy Gy, Selmeci L, Szalay F. Elevated serum dipeptidyl peptidase IV (CD26, E.C.3.4.14.5) activity in patients with primary biliary cirrhosis. J Hepatol 1999;30: 740.
- Perner F, Gyuris T, Rakoczy Gy, Sarvary E, Gorog D, Szalay F, et al. Dipepetidyl peptidase activity of CD26 in serum and urine as a marker of cholestasis: experimental and clinical evidence. J Lab Clin Med 1999;134:56–7.
- Lakatos PL, Firneisz G, Zalatnai A, Selmeci L, Szalay F. Elevated serum dipeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in experimental liver cirrhosis. Eur J Clin Invest 2000; 30:793–7.
- Firneisz G, Lakatos P, Rakoczy Gy, Selmeci L, Szalay F. Serum dipeptidyl peptidase IV (DPP IV, CD26) activity in chronic hepatitis C. An indicator of the response to interferon therapy? Am J Gastroenterol 1998;93:A1681.
- Tanaka T, Kameoka J, Yaron A, Schlossman SF, Morimoto C. The co-stimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc Natl Acad Sci USA 1993;90: 4586–90.
- Duke-Cohan JS, Morimoto C, Rocker JA, Schlossman SF. Serum high molecular weight dypeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells. J Immunol 1996;156: 1714–21.
- Tanaka T, Duke-Cohan JS, Kameoka J, Yaron A, Lee I, Schlossman SF, et al. Enhancement of antigen-induced T-cell proliferation by soluble CD26 /dypeptidyl peptidase IV: Proc Natl Acad Sci USA 1994;91: 3082–6.
- Koziel MJ, Dudley D, Choo D-L, et al. Recognition of HCV proteins by intrahepatic cytotoxic T lymphocytes in persons with chronic hepatitis [Abstract]. Hepatology 1993;18 Suppl:111A.
- Minutello MA, Pileri P, Unutmaz D, Censini S, Kuo G, Houghton M, et al. Compartmentalization of T lymphocytes to the site of disease: intra hepatic CD4 (T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 1993;178:17–25.
- Levy TM, McCaughan WG, Abott AC, Park JE, Cunningham AM, Muller E, et al. Fibroblast activation protein: a cell surface dipeptidyl peptidase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology 1999;29: 1768–78.
- Matsumoto Y, Bishop GA, McCaugham GW. Altered zonal expression of the CD26 antigen (dypeptidyl peptidase IV) in human cirrhotic liver. Hepatology 1992;15: 1048–53.
- Harada T, Kim DW, Sagawa K, Suzuki T, Takahashi K, Sailo I, et al. Characterization of an established human hepatoma cell line constitutively expressing non-structural proteins of hepatitis C virus by transfection of viral cDNA. J Gen Virol 1995;76: 1215–21.
- Gaetaniello L, Fiore M, Filippo S, Pozzi M, Tamasi S, Pignata C, et al. Occupancy of dipeptidyl peptidase IV activates an associated tyrosine kinase and triggers an apoptotic signal in human hepatocarcinoma cells. Hepatology 1998;27:934–42.
- Manns-MP, Obermayer-Straub P. Viral induction of autoimmunity: mechanisms and examples in hepatology. J Viral Hepatol 1997;4 Suppl 2:42–7.
- Mosnier JF, Scoazec JY, Marcellin P, Degott C, Benhamou JP, Feldmann G, et al. Expression of cytokine-dependent immune adhesion molecules by hepatocytes and bile duct cells in chronis hepatitis C. Gastroenterology 1994;107:1457–68.
- Eddleston ALWF. Hepatitis C infection and autoimmunity. J Hepatol 1996;24 2 Suppl:55–60.
- Stecca BA, Nardo B, Chieco P, Mazziotti A, Bolondi L, Cavallari A. Aberrant dypeptidyl peptidase IV (DPP IV/CD 26) expression in human hepatocellular carcinoma. J Hepatol 1997; 27:337–45.